causal

FDA Approval Cost Creates Pharma Cartel

The high cost and delay of FDA approval, while disliked by industry for slowing drugs to market, simultaneously creates a barrier to entry that functions like a cartel protecting incumbent pharmaceutical companies from competition—and these subtle influences give the FDA incentives to keep industry somewhat happy, analogous to the symbiosis between banks and ratings agencies.

causalpending

Speaker

Russ Roberts

Evidence Quote

“it kind of creates a cartel for the pharmaceutical industry... Because there's this huge cost of approving a new drug. And they kind of like that.”

Source

Adam Cifu on Ending Medical Reversal— EconTalk
Created: 6/13/2026, 12:11:12 AM

Your notes

Loading notes...